October 27, 2009
On Friday, I went to the Centers for Medicare & Medicaid Services (CMS) to meet with CMS top leadership ─ Acting Administrator Charlene Frizzera and several of her key Medicare staff. I had the opportunity to introduce her to APhA, our top priorities related to Medicare, and the clinical role…
0 comments
October 19, 2009
In today's Federal Register, FDA reopened the comment period for its Risk Evaluation and Mitigation Strategies, or REMS, for certain opioid drug products. The new deadline for comments--a year from today, 10/19/2010--indicates that no action will be taken for a long while. The move shows that the…
0 comments
October 16, 2009
You are invited to read my editorial in the October Pharmacy Today, due to arrive on your doorstep any day and available online. Since before I returned to APhA staff in February, I've been monitoring various groups' interest in the creation of standards for community pharmacy practice. Some will…
0 comments
October 14, 2009
We all hate to run into heavy traffic on the roads, but when looking at Web and readership of journals and magazines, increased "traffic" is a good thing. At APhA, we've been gratified at the rapid growth and visits to www.pharmacist.com, Facebook, Twitter, and this blog. Since July, our unique…
0 comments
October 13, 2009
Now that all five Senate and House committees have completed their work on health care reform (HCR) bills, we feel good that medication therapy management (MTM) provisions are included in some form in each version. They are not ideal, but the bills represent a good start at ensuring Americans'…
0 comments
October 9, 2009
When I was in practice, I often thought that if only every consumer knew what we pharmacists had to offer, we would all be better off and our advocacy would not be so challenging. What you may not know is how we are getting the word out. Soon, I'll provide you with a report that details the "hits"…
0 comments
October 8, 2009
Pharmacists, please join me in making our collective voice heard at the White House! If you have an account on LinkedIn, log in and then click on the below link. Review APhA's core messages on health care reform, and pick one or two points through which you can blend the big health care problems in…
0 comments
October 7, 2009
Sooner or later, the Senate will consider the controversial issue of prescription drug importation. Today, Senator McCain (R–AZ) called up an amendment to prohibit the use of any Department of Justice funds to investigate or enforce Federal laws related to the importation of prescription drugs. He…
0 comments
October 6, 2009
On Friday, we at APhA hosted hundreds of U.S. Department of State employees for American Pharmacists Month activities at 2215 Constitution Avenue. Various information and screening stations were staffed by a crew of APhA staffers, but the real stars were 50 faculty and students from the pharmacy…
0 comments
September 30, 2009
In a policy paper, Improving FDA Regulation of Prescription Drugs, released Sept. 24, 2009, the American College of Physicians (ACP) proposed that FDA "be given the authority to require new drugs be labeled with a symbol that indicates it is a new drug and that direct-to-consumer advertising be…
0 comments